Norbert G Riedel Eton Pharmaceuticals, Inc. (ETON) insider trading activity

ETON Quotes by TradingView

Norbert G Riedel is Director of Eton Pharmaceuticals, Inc.. Currently has a direct ownership of 162,145 shares of ETON, which is worth approximately $2.88 Million. The most recent transaction as insider was on Jan 03, 2025, when has been sold 102,400 shares (Common Stock) at a price of $3.61 per share, resulting in proceeds of $369,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K
n/a 3M change
n/a 12M change
Total Value Held $2.88 Million

NORBERT G RIEDEL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2025
BUY
Exercise of conversion of derivative security
$369,664 $3.61 p/Share
102,400 Added 38.71%
162,145 Common Stock

Also insider at

CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
APTX
Aptinyx Inc. Healthcare
EXECUTIVE CHAIRMAN OF THE BOD
JAZZ
Jazz Pharmaceuticals plc Healthcare
Director
NGR

Norbert G Riedel

Director
Dublin 4, L2

Track Institutional and Insider Activities on ETON

Follow Eton Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ETON shares.

Notify only if

Insider Trading

Get notified when an Eton Pharmaceuticals, Inc. insider buys or sells ETON shares.

Notify only if

News

Receive news related to Eton Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ETON